Research Radartracking 1,762 published studies · 471 human · 11 safety signals · 58 clinical trials · 44 cancer pages · updated Sep 2026Open the Research Map →
Breast Invasive Ductal Carcinoma (IDC): HER2-enriched (ER–/PR–, HER2+ by IHC/FISH)
Last reviewed: 9/15/2025
Summary
The most common invasive breast cancer. Biology-driven care hinges on ER/PR, HER2, Ki-67, nodal status, stage, and genomic assays.